Impact of Loss-of-function NADPH Oxidase Variants on B cell Activation in SLE
功能丧失的 NADPH 氧化酶变体对 SLE 中 B 细胞激活的影响
基本信息
- 批准号:10577834
- 负责人:
- 金额:$ 53.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdaptive Immune SystemAnimalsAntibodiesAntigensApoptoticAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune ResponsesAutoimmunityAutophagocytosisB-Cell ActivationB-Cell Antigen ReceptorB-LymphocytesBiochemicalCell LineageCell physiologyCellsChronicComplexDataDefectDevelopmentDiseaseEndosomesEventExhibitsFutureGene DeletionGenerationsGenesGenetic ModelsGenetic PolymorphismGenotypeGoalsHematopoieticHumanHuman GeneticsImmuneImmune ToleranceImmune systemImmunizationImmunoglobulin Class SwitchingImmunologicsIn VitroIndividualIntegrin alphaVIntegrin alphaVbeta3IntegrinsInvestmentsKnockout MiceLigandsLinkLoxP-flanked alleleLupusMapsMemoryModelingMusMyelogenousMyeloid CellsNADPH OxidaseNucleic Acid Regulatory SequencesNucleic AcidsOdds RatioOrganOxidasesPathogenesisPathogenicityPathway interactionsPeripheral Blood Mononuclear CellPhagocytesPhagocytosisProductionPublishingReactive Oxygen SpeciesReceptor SignalingRegulationRegulator GenesRiskSignal PathwaySourceStructure of germinal center of lymph nodeSystemSystemic Lupus ErythematosusT-LymphocyteTLR7 geneTestingTissuesToll-like receptorsUntranslated RNAVariantViral AntigensVirus DiseasesVirus-like particleautoreactive B cellcellular imagingdesigndisorder riskgenetic variantgenome wide association studyhumoral immunity deficiencyimaging approachin vivoinsightloss of functionloss of function mutationnew therapeutic targetnovelpathogenic autoantibodiespreventrecruitresponserisk variantsystemic inflammatory responsetargeted treatmenttrafficking
项目摘要
Project abstract
Genome-wide association studies (GWAS) have identified immune pathways linked to the pathogenesis of
systemic lupus erythematosus (SLE). However, despite these insights, our understanding of how individual
genetic variants promote autoimmunity remains poor. Loss-of-function mutations in genes of the phagocytic
NADPH oxidase complex (NOX2), including NCF1 and NCF2, have been linked with the pathogenesis of SLE
and other humoral autoimmune diseases. The current model for how reduced NOX2 activity promotes lupus
development focuses on defects in the clearance of apoptotic material by phagocytic myeloid lineages. While
myeloid defects likely contribute to disease risk, we hypothesize that a parallel B cell-intrinsic mechanism
underlies the profound increase risk of SLE in human carriers of NCF1 and NCF2 variants. In addition to the
production of pathogenic autoantibodies, recent studies have demonstrated that B cells can promote lupus
pathogenesis by initiating immune tolerance breaks and facilitating the generation of spontaneous germinal
centers (GC). The activation of autoreactive B cells in SLE requires B cell-intrinsic expression of the endosomal
toll-like receptors TLR7 and TLR9, and our published and preliminary data show that reduced NOX2 activity
results in dysregulated endosomal TLR signaling by impacting non-canonical autophagy pathways. Based on
these data, we hypothesize that a B cell-specific reduction in NOX2 activity will result in enhanced TLR-
dependent GC formation and the development of humoral autoimmunity. We will test this idea via parallel in vivo
and in vitro mechanistic studies. In Aim 1, we will test whether B cell-intrinsic deletion NOX2 component genes
results in enhanced TLR-dependent GC responses using a well-characterized model of viral infection. In Aim 2,
we will study whether reduced NOX2 activity promotes autoantibody production and humoral autoimmunity in
murine SLE. Finally, in Aim 3, we will use biochemical and cell imaging approaches to test whether NAPDH
oxidase activity impacts B cell TLR signaling and non-canonical autophagy pathways using both murine genetic
models and gene-edited human B cells. Together, these studies promise to advance our understanding of lupus
pathogenesis and may inform the design of future targeted therapies for human SLE.
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shaun William Jackson其他文献
Shaun William Jackson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shaun William Jackson', 18)}}的其他基金
B cell costimulatory signals in the pathogenesis of SLE
SLE 发病机制中的 B 细胞共刺激信号
- 批准号:
10424655 - 财政年份:2019
- 资助金额:
$ 53.66万 - 项目类别:
B cell costimulatory signals in the pathogenesis of SLE
SLE 发病机制中的 B 细胞共刺激信号
- 批准号:
10670450 - 财政年份:2019
- 资助金额:
$ 53.66万 - 项目类别:
B cell costimulatory signals in the pathogenesis of SLE
SLE 发病机制中的 B 细胞共刺激信号
- 批准号:
10169781 - 财政年份:2019
- 资助金额:
$ 53.66万 - 项目类别:
B cell costimulatory signals in the pathogenesis of SLE
SLE 发病机制中的 B 细胞共刺激信号
- 批准号:
10208723 - 财政年份:2019
- 资助金额:
$ 53.66万 - 项目类别:
B cell costimulatory signals in the pathogenesis of SLE
SLE 发病机制中的 B 细胞共刺激信号
- 批准号:
9982781 - 财政年份:2019
- 资助金额:
$ 53.66万 - 项目类别:
B cell costimulatory signals in the pathogenesis of SLE
SLE 发病机制中的 B 细胞共刺激信号
- 批准号:
10434892 - 财政年份:2019
- 资助金额:
$ 53.66万 - 项目类别:
B cell-intrinsic cytokine regulation and B cell-targeted therapies in murine lupu
小鼠狼疮中的 B 细胞内在细胞因子调节和 B 细胞靶向治疗
- 批准号:
8871563 - 财政年份:2014
- 资助金额:
$ 53.66万 - 项目类别:
B cell-intrinsic cytokine regulation and B cell-targeted therapies in murine lupu
小鼠狼疮中的 B 细胞内在细胞因子调节和 B 细胞靶向治疗
- 批准号:
9085227 - 财政年份:2014
- 资助金额:
$ 53.66万 - 项目类别:
B cell-intrinsic cytokine regulation and B cell-targeted therapies in murine lupu
小鼠狼疮中的 B 细胞内在细胞因子调节和 B 细胞靶向治疗
- 批准号:
8759642 - 财政年份:2014
- 资助金额:
$ 53.66万 - 项目类别:
相似海外基金
Single-cell analysis of adaptive immune system cells in IBD patients
IBD 患者适应性免疫系统细胞的单细胞分析
- 批准号:
22KJ2212 - 财政年份:2023
- 资助金额:
$ 53.66万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
- 批准号:
10740465 - 财政年份:2023
- 资助金额:
$ 53.66万 - 项目类别:
Elucidation of the adaptive immune system in teleost fish
阐明硬骨鱼的适应性免疫系统
- 批准号:
22K05824 - 财政年份:2022
- 资助金额:
$ 53.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System
Galectin-9 和妊娠特异性糖蛋白 1 在先天性和适应性免疫系统细胞调节中的相互作用
- 批准号:
10434937 - 财政年份:2021
- 资助金额:
$ 53.66万 - 项目类别:
Peripheral Adaptive Immune System Changes Associated with Alzhiemer's Disease
与阿尔茨海默病相关的外周适应性免疫系统变化
- 批准号:
10194864 - 财政年份:2021
- 资助金额:
$ 53.66万 - 项目类别:
Interaction of Galectin-9 and Pregnancy-Specific Glycoprotein 1 in the Regulation of Cells of the Innate and Adaptive Immune System
Galectin-9 和妊娠特异性糖蛋白 1 在先天性和适应性免疫系统细胞调节中的相互作用
- 批准号:
10302501 - 财政年份:2021
- 资助金额:
$ 53.66万 - 项目类别:
CAREER: Emergence of Functional Organization in the Adaptive Immune System
职业:适应性免疫系统中功能组织的出现
- 批准号:
2045054 - 财政年份:2021
- 资助金额:
$ 53.66万 - 项目类别:
Continuing Grant
Learning a molecular shape space for the adaptive immune system
学习适应性免疫系统的分子形状空间
- 批准号:
10275426 - 财政年份:2021
- 资助金额:
$ 53.66万 - 项目类别:
Learning a molecular shape space for the adaptive immune system
学习适应性免疫系统的分子形状空间
- 批准号:
10669709 - 财政年份:2021
- 资助金额:
$ 53.66万 - 项目类别:
Learning a molecular shape space for the adaptive immune system
学习适应性免疫系统的分子形状空间
- 批准号:
10467050 - 财政年份:2021
- 资助金额:
$ 53.66万 - 项目类别: